Solventum Corp. (SOLV) - Total Liabilities
Based on the latest financial reports, Solventum Corp. (SOLV) has total liabilities worth $8.99 Billion USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Solventum Corp. - Total Liabilities Trend (2021–2024)
This chart illustrates how Solventum Corp.'s total liabilities have evolved over time, based on quarterly financial data. See SOLV working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Solventum Corp. Competitors by Total Liabilities
The table below lists competitors of Solventum Corp. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Henkel AG & Co. KGaA vz. (Pref Shares)
XETRA:HEN3
|
Germany | €12.67 Billion |
|
Origin Energy Ltd
AU:ORG
|
Australia | AU$10.37 Billion |
|
Advanced Energy Industries Inc
NASDAQ:AEIS
|
USA | $1.21 Billion |
|
Hyundai Autoever Corp
KO:307950
|
Korea | ₩1.48 Trillion |
|
Straumann Holding AG
SW:STMN
|
Switzerland | CHF1.65 Billion |
|
ZTO Express (Cayman) Inc
F:ZTOA
|
Germany | €25.18 Billion |
|
The Siam Commercial Bank Public Company Limited
BK:SCB-R
|
Thailand | ฿3.02 Trillion |
|
NAT.B.GR. SPONS.ADR/1
F:NAG
|
Germany | €69.80 Billion |
Liability Composition Analysis (2021–2024)
This chart breaks down Solventum Corp.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Solventum Corp. worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.50 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.80 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.64 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Solventum Corp.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Solventum Corp. (2021–2024)
The table below shows the annual total liabilities of Solventum Corp. from 2021 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $11.50 Billion | +404.96% |
| 2023-12-31 | $2.28 Billion | +22.95% |
| 2022-12-31 | $1.85 Billion | -8.13% |
| 2021-12-31 | $2.02 Billion | -- |
About Solventum Corp.
Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates in three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions for negative pressure wound therapy, advanced wound dressings, advance… Read more